A provocative article by author Jon Wiener in the August 7 issue of The Nation magazine raises intriguing questions about Los Angeles Medicare fraud. Specifically, Wiener asks whether academics who indirectly create/perpetuate medical fraud in Southern California and elsewhere should be punished. And if so, how?
Wiener’s editorial concerns recent GlaxoSmithKline healthcare fraud charges. The giant drug maker pled guilty on July 3rd and agreed to pay out approximately $3 billion in connection with promoting antidepressant pharmaceuticals for uses that had not been approved. At the center of the case was a medical journal article that seemed to give Paxil a pass. The article essentially said Paxil was safe and effective for helping children with depression.
The authors who contributed to the article included Dr. David Feinberg, the head of UCLA’s hospital. But a Department of Justice investigation found out that the pharmaceutical company had paid for that journal article – which critics said “dangerously misrepresented dangers and [hid] information indicating that the drug promoted suicidal behavior among teenagers.”